-
Diagnostics World News | New tools for predicting COVID-19 severity and death, and screening results of more than 1,000 at-home COVID-19 tests. Plus: detecting COVID-19 in wastewater, saliva-based testing for SARS CoV-2, uncovering the immunologic pathways of MIS-C.
Feb 12, 2021
-
Diagnostics World News | The European Union’s In Vitro Diagnostic Regulation (IVDR), introduced a new risk-based classification system, significantly impacting complementary and companion diagnostics. The IVDR also defines a CDx, for the first time in Europe, creating new challenges for device manufacturers and pharmaceutical companies producing CDx.
Feb 11, 2021
-
Diagnostics World News | Because coronavirus can spread before people become aware of their symptoms—or when they experience no symptoms whatsoever—some are turning to wearables as an early detection tool. By picking up on changes in certain metrics, smartwatches may be able to help curb transmission by providing indications of infection and nudging individuals to self-isolate or get tested sooner.
Feb 9, 2021
-
Diagnostics World News | Biomarker for patients with an increased risk of bleeding, detecting antibodies in minutes, self-swabbing just as accurate as those taken by healthcare workers, routine screening of asymptomatic healthcare personnel not an effective strategy, and breath-sampling whistle captures aerosols for COVID-19 testing. Plus: Startup develops test using genetically modified brewer’s yeast and George Mason University expands saliva-based testing on campus after successful results in the Fall.
Feb 5, 2021
-
Diagnostics World News | With the increasing number of FDA-approved targeted therapies and immunotherapies, comprehensive genomic profiling is becoming a standard diagnostic tool for patients with cancer. CGP is a test methodology that uses next-generation sequencing to simultaneously assess the four main classes of genomic alterations that may be responsible for driving cancer growth.
Feb 3, 2021
-
Diagnostics World News | As more targeted therapies become available to cancer patients based on the phenotype of their tumor, so too will understanding of the tumor habitats to reduce—and perhaps eventually eliminate—the need for biopsies before, during, and after treatment. That is the promise of computational approach being developed by researchers at the University of Cambridge (U.K.) combining routine computerized tomography (CT) and ultrasound (US) images to create a visual guide for doctors as they obtain tissue samples.
Feb 2, 2021
-
Diagnostics World News I New diagnostic assay allows testing and genomic surveillance simultaneously, a portable and bifunctional electrical detector for SARS-CoV-2, 1 in 3 infected asymptomatic. Plus: Melatonin produced in lungs could be used as a prognostic biomarker and machine learning predicts COVID-19 patient outcomes.
Jan 29, 2021
-
Diagnostics World News | Saliva for early lunch cancer detection, new guidelines for diagnosis of bleeding disorder, Babson claims fingerstick diagnostics in a retail setting, and looking at Alzheimer’s. Plus: companion diagnostic agreements, and genomic sequencing for prenatal testing.
Jan 28, 2021
-
Diagnostics World News | Moffitt Cancer Center researchers have discovered a way to pinpoint a subset of prostate cancer patients with aggressive tumors who may benefit from combined immune-radiotherapy modalities. The answer gets computed from a combination of the immune content score (ICS) and the 22-gene Decipher classifier score that is predictive of metastasis.
Jan 25, 2021
-
Diagnostics World News | Quantified smell loss the best predictor of COVID-19 among those with symptoms, the outlook for self-tests, circulating mitochondria as a warning of severe disease, and more. Plus: QIAGEN’s PCR test stands up to new variants, new development on tests to distinguish between SARS-CoV-2 and influenza.
Jan 22, 2021